Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18755840rdf:typepubmed:Citationlld:pubmed
pubmed-article:18755840lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:18755840lifeskim:mentionsumls-concept:C0007114lld:lifeskim
pubmed-article:18755840lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:18755840lifeskim:mentionsumls-concept:C1442792lld:lifeskim
pubmed-article:18755840lifeskim:mentionsumls-concept:C1514185lld:lifeskim
pubmed-article:18755840pubmed:issue10lld:pubmed
pubmed-article:18755840pubmed:dateCreated2008-9-29lld:pubmed
pubmed-article:18755840pubmed:abstractTextRenewal of stem cells differs from cancer cell growth in self-controlled cell division. The mir-302 microRNA (miRNA) family (mir-302s) is expressed most abundantly in slow-growing human embryonic stem (ES) cells, and quickly decreases after cell differentiation and proliferation. Therefore, mir-302s was investigated as one of the key factors essential for maintenance of ES cell renewal and pluripotency in this study. The Pol-II-based intronic miRNA expression system was used to transgenically transfect the mir-302s into several human cancer cell lines. The mir-302-transfected cells, namely, miRNA-induced pluripotent stem (mirPS) cells, not only expressed many key ES cell markers, such as Oct3/4, SSEA-3, SSEA-4 ,Sox2, and Nanog, but also had a highly demethylated genome similar to a reprogrammed zygotic genome. Microarray analyses further revealed that genome-wide gene expression patterns between the mirPS and human ES H1 and H9 cells shared over 86% similarity. Using molecular guidance in vitro, these mirPS cells could differentiate into distinct tissue cell types, such as neuron-, chondrocyte-, fibroblast-, and spermatogonia-like primordial cells. Based on these findings, we conclude that mir-302s not only function to reprogram cancer cells into an ES-like pluripotent state but also to maintain this state under a feeder-free cultural condition, which may offer a great opportunity for therapeutic intervention.lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:languageenglld:pubmed
pubmed-article:18755840pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:citationSubsetIMlld:pubmed
pubmed-article:18755840pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18755840pubmed:statusMEDLINElld:pubmed
pubmed-article:18755840pubmed:monthOctlld:pubmed
pubmed-article:18755840pubmed:issn1469-9001lld:pubmed
pubmed-article:18755840pubmed:authorpubmed-author:LinShi-LungSLlld:pubmed
pubmed-article:18755840pubmed:authorpubmed-author:YingShao-YaoS...lld:pubmed
pubmed-article:18755840pubmed:authorpubmed-author:LinChun-HungC...lld:pubmed
pubmed-article:18755840pubmed:authorpubmed-author:ChangDonald...lld:pubmed
pubmed-article:18755840pubmed:authorpubmed-author:ChenDavid TDTlld:pubmed
pubmed-article:18755840pubmed:authorpubmed-author:Chang-LinSama...lld:pubmed
pubmed-article:18755840pubmed:authorpubmed-author:WuDavid T SDTlld:pubmed
pubmed-article:18755840pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18755840pubmed:volume14lld:pubmed
pubmed-article:18755840pubmed:ownerNLMlld:pubmed
pubmed-article:18755840pubmed:authorsCompleteYlld:pubmed
pubmed-article:18755840pubmed:pagination2115-24lld:pubmed
pubmed-article:18755840pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:meshHeadingpubmed-meshheading:18755840...lld:pubmed
pubmed-article:18755840pubmed:year2008lld:pubmed
pubmed-article:18755840pubmed:articleTitleMir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state.lld:pubmed
pubmed-article:18755840pubmed:affiliationDepartment of Cell and Neurobiology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA. lins@usc.edulld:pubmed
pubmed-article:18755840pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18755840lld:pubmed